Wei Bu, PhD

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States

Disclosure information not submitted.

Presentation(s):

• 182 - Progress towards an EBV vaccine: Results of a Phase I, First-In-Human EBV gp350 Ferritin Nanoparticle Vaccine Candidate adjuvanted with Matrix-M®

  Monday, October 20, 2025
  2:09 PM - 2:21 PM US ET